Research Analysts Issue Forecasts for SNDX Q1 Earnings
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) – Equities researchers at B. Riley issued their Q1 2025 EPS estimates for Syndax Pharmaceuticals in a report issued on Monday, March 3rd. B. Riley analyst K. Patel expects that the company will post earnings of ($1.11) per share for the quarter. The consensus estimate for Syndax Pharmaceuticals’ ...
Publicado el: 2025-03-06 06:18:26
Autor: MarketBeat News, Fuente: etfdailynews
Compartir: 
